Mingowood has created a patented stabilized formulation of CBDA, CBGA, THCA, and CBCA!

Welcome to Mingowood Pharmacal. Our mission is to unlock the full potential of acidic cannabinoids through innovative formulation technology, delivering stabilized and efficacious solutions to diverse high-value markets. We are dedicated to maximizing the therapeutic benefits of acidic cannabinoids, including CBDA, THCA, CBGA, and CBCA. Using HPLC, ATR-FTIR, and UV-Vis spectroscopy we have demonstrated an order-of-magnitude reduction in the decay constant of CBDA and CBGA in our intercalated cannabinoids, compared to the pure compound. See our website.